What is MORN's health score?

Morningstar, Inc. (MORN) has a TradeApes health score of 68 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MORN's estimated fair value?

Based on our 5-year discounted cash flow model, Morningstar, Inc.'s estimated fair value is $75.77 per share, representing a -59.1% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MORN undervalued or overvalued?

Our model currently rates MORN as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MORN... Refresh in a moment for the full analysis.

Morningstar, Inc. (MORN)

Financials Overvalued low healthy

$185.18

Updated: 2026-06-05

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

63 Healthy

Relative Value

75 Strong

Capital Allocation

60 Healthy

Risk

70 Healthy

Est. Fair Value $75.77

DCF Upside -59.1%

Sector Rank #164 of 6299

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Debt increasing — total debt up more than 10% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.